GIGAVIS LTD (PROPOSED) (420770.KQ) stock: key figures, P/E, revenue and dividend
Information Technology · South Korea · ISIN KR7420770000
Price
62,600.00 KRW
Market cap
793.50 bn KRW
P/E (2025)
51.35
P/S (2025)
15.13
Dividend yield
1.28 %
Net margin
29.47 %
Return on equity (ROE)
7.32 %
Return on assets (ROA)
6.46 %
GIGAVIS LTD (PROPOSED) financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 26.13 bn KRW | 52.43 bn KRW |
| Gross profit | 12.11 bn KRW | 28.37 bn KRW |
| Operating income | -1.79 bn KRW | 12.10 bn KRW |
| EBIT | 5.06 bn KRW | 16.08 bn KRW |
| Net income | 3.41 bn KRW | 15.45 bn KRW |
| Diluted EPS – continuing operations | 269.18 KRW | 1,219.04 KRW |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About GIGAVIS LTD (PROPOSED)
GigaVis Co., Ltd. researches, develops, and supplies vision inspection systems in South Korea and internationally. It offers verify repair system, automatic optical repair, in-line equipment, automated optical inspection systems, and factory automation systems. The company was founded in 2004 and is based in Pyeongtaek-si, South Korea.
More stocks
- Winstek Semiconductor Co Ltd (3265.TWO)
- Sercomm Corp (5388.TW)
- Oeneo SA (SBT.PA)
- Tianjin Jiuri New Materials Co Ltd (688199.SS)
- Centrotec Se (CEV.HM)
- Hangzhou Minsheng Healthcare Co Ltd (301507.SZ)
- Chong Kun Dang Pharmaceutical (185750.KS)
- Shanghai Shuixing Home Textile Co Ltd Class A (603365.SS)
- Hangzhou AGS MedTech Co. Ltd. A (688581.SS)
- Aclaris Therapeutics, Inc. (ACRS)
- Mengtian Home Group Inc. (603216.SS)
- Beijing ZznodeTechnologies Co Ltd (003007.SZ)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.